Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc is a Healthcare company operating in Biotechnology with a $2.2M market cap.
Most recent earnings call: Q2 FY21 on Sep 20, 2021.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks BDRX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BDRX.
$ curl https://api.spokenalpha.com/v1/companies/BDRXFAQ
Spoken Alpha indexes BDRX's earnings call transcripts at https://spokenalpha.com/companies/BDRX. Each call links to attributed speakers and parsed analyst Q&A. Biodexa Pharmaceuticals Plc's own investor relations page is at https://biodexapharma.com/investors/.
Biodexa Pharmaceuticals Plc (BDRX) held its most recent earnings call on 2021-09-20, covering fiscal Q2 2021.
Biodexa Pharmaceuticals Plc (BDRX) operates in the Healthcare sector (Biotechnology industry).
When a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2021 | $2.62 | $2.42 | +8.1% | -7.1% | -8.9% |
| Q4 FY2021 | $2.73 | $2.39 | +14.2% | -3.2% | -5.2% |
| Q3 FY2021 | $2.98 | $2.56 | +16.5% | -7.4% | -10.0% |
| Q2 FY2021 | $2.97 | $2.61 | +13.9% | -0.2% | +0.3% |
| Q1 FY2020 | $2.87 | $2.61 | +9.9% | -6.3% | -5.5% |
| Q4 FY2020 |
| $3.04 |
| $2.56 |
| +18.9% |
| -6.4% |
| -7.4% |
| Q3 FY2020 | $2.76 | $2.48 | +11.2% | +2.8% | +4.2% |
| Q2 FY2020 | $2.80 | $2.62 | +6.8% | -3.8% | -6.3% |
| Q1 FY2019 | $3.11 | $2.71 | +14.8% | +2.5% | +1.2% |
| Q4 FY2019 | $3.03 | $2.71 | +11.7% | -1.9% | -0.2% |